Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 2:50 AM
Ignite Modification Date: 2025-12-26 @ 1:32 AM
NCT ID: NCT05147233
Description: None
Frequency Threshold: 5
Time Frame: From first dose until Day 90
Study: NCT05147233
Study Brief: A Phase 3 Study Evaluating the Efficacy and Safety of OCS-01 Eyedrops Compared to Vehicle for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Vehicle 1 drop of vehicle in the study eye QD for 14 days, beginning 1-day post-surgery in the study eye. 0 None 1 122 8 122 View
OCS-01 1 drop of OCS-01 in the study eye QD for 14 days, beginning 1-day post-surgery in the study eye. 0 None 0 119 2 119 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Covid-19 SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (25.0) View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Eye Pain SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (25.0) View